Pancreatic Cancer Research

ResearcherFujian Medical UniversityNo recent work listed

Youting Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1446-5477; OpenAlex author ID A5030808636. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 4

  1. CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway. Last author DOI 10.1016/j.abb.2023.109760↗
  2. DDIT4 Novel Mutations in Pancreatic Cancer. Co-author DOI 10.1155/2021/6674404↗
  3. DDIT4 is involved in PPAR-γ mediated Fatty Acid intake to promote the Proliferation of Pancreatic Cancer Last author DOI 10.21203/rs.3.rs-157763/v1↗
  4. PRSS1 genotype is associated with prognosis in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ol.2019.11097↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fadian Ding · 3 shared papers, 2020–2021 · strength 0.39
  2. Qicai Liu · 3 shared papers, 2020–2021 · strength 0.39
  3. Rongwen Ou · 1 shared paper, 2023 · strength 0.31
  4. Chengjie Lin · 1 shared paper, 2023 · strength 0.31
  5. Feng Gao · 2 shared papers, 2021 · strength 0.27
  6. Shuyu Zhang · 1 shared paper, 2021 · strength 0.13
  7. Huasheng Wu · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.